Cargando…
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
BACKGROUND: Development of an effective vaccine against the pathogenic blood-stage infection of human malaria has proved challenging, and no candidate vaccine has affected blood-stage parasitemia following controlled human malaria infection (CHMI) with blood-stage Plasmodium falciparum. METHODS: We...
Ejemplares similares
-
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
por: Salkeld, Jo, et al.
Publicado: (2022) -
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
por: Folegatti, Pedro M, et al.
Publicado: (2020) -
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
por: Miura, Kazutoyo, et al.
Publicado: (2023) -
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
por: Srinivasan, Prakash, et al.
Publicado: (2017) -
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
por: Folegatti, Pedro M., et al.
Publicado: (2019)